Consultations

Pursuant to The Pharmaceutical Act and Regulations and the Policy Statement on Practice Directions, CPhM welcomes the feedback of all stakeholders, including members of the public, through a transparent consultation process.

The College of Pharmacists of Manitoba (CPhM) prioritizes the input and perspectives of the public, pharmacy professionals, and other community partners in Manitoba. Consultations are how CPhM can seek feedback on proposed policies, guidelines, and initiatives aimed at enhancing the safety and effectiveness of pharmacy practice in Manitoba. By engaging with diverse audiences, we ensure that decisions are well-informed and reflective of the needs and expectations of those we serve. Your participation is invaluable in helping us fulfill our mandate to protect public health and uphold the standards of pharmacy practice. 

 

Open Consultations

 

Consultation on Proposed Amendments to the Pharmaceutical Regulation to Allow Pharmacy Students to Administer Drugs and Vaccines

CPhM invites feedback from pharmacy professionals, system partners and the public on the following proposed amendments: 

  • Proposed Amendment 1: Section 62(2) is added to allow pharmacy students in at least the second year of their program to administer drugs or vaccines, if the student is under direct supervision of a pharmacist who is authorized to administer drugs/vaccines and the student has completed training approved by Council as part of their pharmacy educational program. Pharmacy students may only administer drugs and vaccines prescribed by an “authorized practitioner” or those listed in Schedule 2 to the Regulation, according to the requirements of the provincial immunization program. At this time, pharmacy students would not be permitted to administer a drug prescribed for contraception, unless it is prescribed by an “authorized practitioner” (note: pharmacists are not considered “authorized practitioners” under federal legislation). 
  • Proposed Amendment 2: Sections 111 and 113 are amended to require recordkeeping of the pharmacy student’s administration of a drug or vaccine. 
  • Proposed Amendment 3: Several minor clarification amendments are also proposed: 
    1. Removing the definition of Personal Health Identification Number (PHIN) as this term is not used in the Pharmaceutical Regulation and is defined in other legislation. 
    2. Correcting the French version of section 64, subsection 108(2), and section 110. 
    3. Correcting the language used to describe the government entity responsible for maintaining the public health information network, in section 111. 

For more information, please visit https://cphm.ca/consultation-on-proposed-amendments-to-the-pharmaceutical-regulation-to-allow-pharmacy-students-to-administer-drugs-and-vaccines/.

 

If you have any questions, please email info@cphm.ca. 

Closed Consultations

Information about closed consultations can be found here:

Consultation on a New Virtual Care Practice Direction and Changes to the Prescribing Practice Direction

Thank you to everyone who participated in this Consultation on a New Virtual Care Practice Direction and Changes to the Prescribing Practice Direction.

 

CPhM invited feedback from pharmacy professionals, system partners and the public on the following proposed changes: 

  1. New practice direction: a new practice direction on virtual care has been created. 
  2. Amendments to the Prescribing Practice Direction: Section 2.4 has been amended to remove the requirement for a pharmacist’s prescribing assessment to include in-person or face-to-face communication, allowing for a virtual assessment if it is compliant with the new Virtual Care Practice Direction. Sections 2.4.1 and 2.4.2 have been amended to include virtual assessment and follow up by a regulated health care provider.  
  3. Exemption to be repealed: The existing exemption to section 2.4 of the Prescribing Practice Direction (which currently   provides an exemption to the requirement for in person or face-to-face communication when a pharmacist is prescribing) will be repealed. This exemption will no longer be required.    

All feedback and comments will be reviewed and considered by Council.  

 

If you have any questions, please email info@cphm.ca. 

Consultation on Proposed Amendments to the Pharmaceutical Regulation Administering and Prescribing Hormonal Contraceptives Drugs

Thank you to everyone who participated in this Consultation on Proposed Amendments to the Pharmaceutical Regulation Administering and Prescribing Hormonal Contraceptives Drugs.

 

CPhM invited feedback from all registrants, system partners, and the public on the following proposed amendments: 

  1.  Amendment to Section 110: This amendment will allow injection-authorized pharmacists to administer a drug that is prescribed for contraception. 
  2.  Added to Section 118: A pharmacist who has completed training approved by the council may prescribe a contraceptive drug product authorized by Health Canada in the following dosage forms:
    1.  an oral contraceptive,
    2. a transdermal patch,
    3. a vaginal ring,
    4. a solution administered through intradermal, subcutaneous or intramuscular injection. 

 

All feedback and comments will be reviewed and considered by Council.  

 

If you have any questions, please email info@cphm.ca. 

Consultation on Changes to the Joint Practice Direction: Electronic Transmission of Prescriptions

Thank you to everyone who participated in this Consultation on Changes to the Joint Practice Direction: Electronic Transmission of Prescriptions. 

 

CPhM invited feedback from all registrants, system partners, and the public on the following propsed amendments: 

  • Addition of the College of Midwives of Manitoba (CMM) to the Joint Practice Direction. 
  • Addition of a section requiring prescriptions from midwives to include a treatment goal and/or diagnosis and/or clinical indication. 
  • Amending the section requiring total quantity and interval between part-fills to be specified for any medication on the M3P list, as well as any medication classified federally as a narcotic or controlled drug (previously this section said “narcotic or controlled substance”).
  • Amending Appendix A to refer only to narcotic or controlled drugs.

 

All feedback and comments are reviewed and considered by Council. 

 

If you have any questions, please email info@cphm.ca. 

Consultation on Proposed Changes to CPhM Practice Directions and Guidelines

Thank you to everyone who participated in this Consultation on Proposed Changes to CPhM Practice Directions and Guidelines.

 

CPhM invited feedback from all registrants, system partners, and the public on the following documents: 

  • New Documents
    • These documents have been newly created:
      • Informed Consent Practice Direction (new)
      • Informed Consent Guideline (new)
      • Compliance Packaging Practice Direction (new)
      • Compliance Packaging Guideline (new)
  • Revised Documents
    • These are existing documents that have been updated:
      • Drug Distribution and Storage Practice Direction (revised)
      • Ensuring Patient Safety Practice Direction (revised)
      • Controlled Substance Accountability Guideline (revised)
      • Administration of Drugs Including Vaccines Practice Direction (revised)
      • Permanent and Temporary Pharmacy Closures Practice Direction (revised)

All feedback and comments are reviewed and considered by Council. 

 

If you have any questions, please email info@cphm.ca. 

Proposed Amendments to the Pharmaceutical Regulation for Pneumococcal Vaccines

Thank you to everyone who participated in this consultation on proposed amendments to the Pharmaceutical Regulation for Pneumococcal Vaccines. 

 

CPhM invited feedback from all registrants, system partners, and the public on the following proposed amendments: 

  1. Amendment to Schedule 2: This amendment will allow injection certified pharmacists to administer any of the two publicly funded pneumococcal vaccines, as well as any future publicly funded pneumococcal vaccines. 
  2. Update to Hospital Definition: The definition of “hospital” in the Pharmaceutical Regulation will be updated to reference the “Health Services Insurance Act” instead of “The Hospitals Act”.   

All feedback and comments are reviewed and considered by Council. 

 

If you have any questions, please email info@cphm.ca 

Consultation on Proposed Bylaw Draft

Background

In 2020, Council of the College of Pharmacists of Manitoba (CPhM) initiated a comprehensive review of its current governance framework. This process aimed to modernize the framework and enhance its alignment with the principles of transparency, accountability, and a commitment to the public interest. Upon completing this initial review, the Governance Committee, in close collaboration with CPhM Council, proceeded to refine the bylaws, incorporating the recommended changes.  

 

Town Hall Follow-Up: Q&A Insights

On January 29, 2024, a virtual town hall meeting was held as a supplement to the consultation process for proposed amendments to the CPhM Bylaws. All registrants were informed of the town hall and had the opportunity to attend the virtual event. During the meeting, attendees were presented with the highlights of the draft bylaws based on feedback received and engaged in a live Q&A session. Many questions had overlapping themes and subjects.

The following document summarizes the questions asked during the event, grouped by common themes: CPhM Townhall Q&A

If you have any comments or questions, please send to info@cphm.ca 

Changes to the Electronic Transmission of Prescriptions Practice Direction and the Manitoba Prescribing Practices Program (M3P)

Thank you to everyone who participated in this consultation on proposed changes to the Electronic Transmission of Prescriptions Practice Direction and the Manitoba Prescribing Practices Program (M3P).

CPhM invited feedback from all registrants, stakeholders, and the public on the following proposed changes:

  • Allowing transfers of CDSA prescriptions
  • Updated Joint Practice Direction for Electronic Transmission of Prescriptions
  • Elimination of the Joint Statement on Prescribing Practices: Doctor/Pharmacist Relationships
  • Replacement of the personalized M3P paper pads with standardized templates
  • Addition of Codeine Products to the list of drugs covered under the M3P

All feedback and comments received are reviewed and considered by Council.

If you have any questions, please email info@cphm.ca 

Consultation Process

In order to help guide the development of regulations, policies, guidelines and other documents related to pharmacy practice, CPhM periodically requests input from registrants of the profession, the public and community partners in Manitoba. 

Documents that are available for consultation are posted on the CPhM website with clearly specified submission deadlines and questions to guide your feedback.  

The CPhM Council and relevant staff members review and consider all feedback before finalizing any policy, guideline or other documents. 

Consultation Framework 

The College of Pharmacists of Manitoba (CPhM) is dedicated to engaging with members, the public, and stakeholders in the development of policies, guidelines, and regulations. The Regulation Amendment and Consultation Process ensures that feedback is solicited, considered, and valued, in line with CPhM’s mission and values. 

Identification of Regulations Requiring Amendment 

Council may receive requests to amend or repeal regulations from committees, members, or the Registrar. An individual or group may be tasked with researching and drafting the proposed changes. 

Consultation, Feedback, and Development Process 

  1. Proposal Creation: CPhM staff compiles a list of proposed regulation changes with rationale, focusing on patient care and safety. 
  2. Initial Review: Consultation with the Executive of the Canadian Society of Hospital Pharmacists and Pharmacists Manitoba. 
  3. Public Feedback: Registrants, the public, and stakeholders review and provide feedback on proposed changes. 
  4. Government Consultation: A meeting with Manitoba Health, including the Deputy Minister and Legislative Drafting Unit, to discuss the changes. 
  5. Council Review: A draft of the regulations is submitted to Council for consideration. 

Feedback Process 

  1. Written Feedback: Members and stakeholders can submit written feedback to the Registrar and/or President, including clear objectives and rationale. 
  2. Special General Meetings: Upon request by at least 5% of voting members, Council will convene a meeting to discuss concerns about proposed regulations. Council must respond to all motions within 90 days. 

Approval and Implementation 

Council will consider all feedback and the results of the development process before finalizing new or amended regulations. The focus remains on improving patient care and safety, with a clear implementation plan and communication to all relevant parties. 

Review Process 

Council continuously reviews and assesses regulations to ensure their effectiveness and appropriateness. The feedback mechanisms are always available for member input. 

Urgent Matters 

In urgent situations, such as a pandemic or public health crisis, Council may develop regulations quickly but will follow the review and feedback process as soon as possible.